Figure 4 — The adhesion molecule ICAM-1 in diffuse large B-cell lymphoma post-rituximab era: relationship with prognostic importance and rituximab resistance

Research Paper|Volume 13, Issue 1|pp. 181–193

The adhesion molecule ICAM-1 in diffuse large B-cell lymphoma post-rituximab era: relationship with prognostic importance and rituximab resistance

Back to articleFigure 4(4 of 5)

100%

Figure 4.Cellular aggregation in RSCL and RRCL treated with rituximab. Rituximab enhances cellular aggregation in both ICAM-1 high expressed RSCL and ICAM-1 low expressed RRCL.